Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

Martina Penazzato(World Health Organization), Magda Conway, Tim R. Cressey, Yodit Belew, Shaffiq Essajee(United Nations Children's Fund), Anna Turkova(Great Ormond Street Hospital), Carmen Pérez Casas, Mutsa Dangarembizi, Victor Musiime(Joint Clinical Research Centre), Shahin Lockman(Brigham and Women's Hospital), Angela Mushavi(Ministry of Health and Child Welfare), Theodore Ruel(University of California, San Francisco), Isabelle Andrieux‐Meyer(Drugs for Neglected Diseases Initiative), Saye Khoo(University of Liverpool), Angela Colbers, Pablo Rojo(Research Institute Hospital 12 de Octubre), Nandita Sugandhi(ICAP Global Health), Anton Pozniak, Helena Rabie(Stellenbosch University), Maribel Gonzalez Tome, Jintanat Ananworanich(Henry M. Jackson Foundation), Elaine J. Abrams(ICAP Global Health), Andrew Hill(University of Liverpool), Jessica Burry, Rosa Bologna, Linda Lewis, Maria Kim, Imelda Mahaka, Polly Clayden, Brookie M. Best, Claire L Townsend(World Health Organization), Fernando García Pascual, Moherndran Archary(Africa Health Research Institute), Natella Rakhmanina(Elizabeth Glaser Pediatric AIDS Foundation), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Meg Doherty(World Health Organization), Janice Lee(Harvard University), Yao I. Cheng(Shenyang 242 Hospital), Elizabeth Obimbo, Mark Mirochnick(Boston University), Deborah Carpenter, Maria H. Kim(Baylor College of Medicine), M.A. Muhimpundu
The Lancet HIV
September 1, 2019
Cited by 61


Related Papers